51904-91-7

Basic information

• Product Name: 5-chlorosulphonyl-2-anisic acid
• Synonyms: 5-chlorosulphonyl-2-anisic acid;2-Methoxy-5-(chlorosulfonyl)benzoic acid;3-Carboxy-4-methoxybenzenesuofonyl chloride;Einecs 257-507-7;3-Carboxy-4-methoxybenzenesulphonyl chloride, 2-Carboxy-4-(chlorosulphonyl)anisole
• CAS NO: 51904-91-7
• Molecular Formula: C₈H₇ClO₅S
• Molecular Weight: 250.65618
• EINECS: 257-507-7
• Mol File: 51904-91-7.mol
• Article Data: 7

Chemical Properties

• Melting Point: 147-149 °C(Solv: dichloromethane (75-09-2))
• Boiling Point: 441.8°Cat760mmHg
• Flash Point: 221°C
• Appearance: /
• Density: 1.541g/cm³
• Vapor Pressure: 1.39E-08mmHg at 25°C
• Refractive Index: 1.565
• Storage Temp.: under inert gas (nitrogen or Argon) at 2-8°C
• PKA: 2.89±0.10(Predicted)
• Sensitive: Moisture Sensitive
• CAS DataBase Reference: 5-chlorosulphonyl-2-anisic acid(CAS DataBase Reference)
• NIST Chemistry Reference: 5-chlorosulphonyl-2-anisic acid(51904-91-7)
• EPA Substance Registry System: 5-chlorosulphonyl-2-anisic acid(51904-91-7)

Safety Data

• HazardClass: IRRITANT
• Hazardous Substances Data: 51904-91-7(Hazardous Substances Data)

Usage

General Description

5-chlorosulphonyl-2-anisic acid is a chemical compound that is a derivative of anisic acid, which in turn is a type of benzoic acid. It features a specific molecular structure that includes a chlorosulfonyl group attached to the 5th carbon atom and an anisic acid group attached to the 2nd carbon atom. This distinct structure contributes to its unique chemical properties and potential uses. However, specific detailed information about its physical properties, such as melting point, boiling point, or solubility, possible applications, and safety measures are not readily available, indicating that further research may be needed.

InChI:InChI=1/C8H7ClO5S/c1-14-7-3-2-5(15(9,12)13)4-6(7)8(10)11/h2-4H,1H3,(H,10,11)

Upstream product

• 579-75-9 2-Methoxybenzoic acid 
• 100-09-4 4-methoxybenzoic acid 

Downstream Products

• 22117-85-7 2-methoxy-5-sulfamoylbenzoic acid 
• 71993-03-8 3,3'-dithiobis(6-methoxybenzoic acid) 
• 80530-56-9 5-mercapto-2-methoxybenzoic acid 
• 50390-76-6 2-methoxy-5-methylsulphonylbenzoic acid 
• 93798-20-0 5-dimethylaminosulfonyl-2-methoxybenzoic acid 
• 69046-20-4 5-Dimethylaminosulfonyl-2-methoxybenzoic acid chloride 
• 67833-50-5 N-(2,5-dichloropentyl)-2-methoxy-5-sulfamoylbenzamide 
• 118894-84-1 N-<(2-tetrahydrothienyl)methyl>-2-methoxy-5-sulfamoylbenzamide 
• 118894-85-2 2-<(2-methoxy-5-sulfamoylbenzamido)methyl>-1-ethyltetrahydrothiophenium iodide 
• 61694-97-1 2-methoxy-5-(methylthio)benzoic acid 
• 5378-41-6 2-hydroxy-5-sulfonamidobenzoic acid 
• 651728-16-4 2-(p-toluenesulfonyl)ethyl 5-chlorosulfonyl-2-methoxybenzoate 
• 69185-96-2 5-chlorosulfonyl-2-methoxybenzoic acid chloride 
• 1416001-58-5 4-((2S)-2-(3-(3-carboxy-4-methoxyphenylsulfonyl)-thiazolidine-2-carbonyloxy)-2-(3-(cyclopropylmethoxy)-4-(difluoromethoxy)phenyl)ethyl)-3,5-dichloropyridine 1-oxide 

Relevant articles and documents

SULPHAMOYLARYL DERIVATIVES AND USE THEREOF AS MEDICAMENTS FOR THE TREATMENT OF LIVER FIBROSIS

Potent 5-HT2B antagonist of Formula (A), including stereochemically isomeric forms, and salts, hydrates, solvates thereof and their use wherein R1 to R4 and Ar have the meaning as defined herein. The present invention also relates to processes for preparing said compounds, pharmaceutical compositions containing them, alone or in combination with other drugs, in fibrosis and/or cirrhosis prevention or therapy.

1-arylsulfonyl-2-(Pyridylmethylsulfinyl) benzimidazoles as new proton pump inhibitor prodrugs

New arylsulfonyl proton pump inhibitor (PPI) prodrug forms were synthesized. These prodrugs provided longer residence time of an effective PPI plasma concentration, resulting in better gastric acid inhibition.

PRODRUGS OF PROTON PUMP INHIBITORS

Prodrugs of proton pump inhibitors of Formulas 1 through 4, (I-IV), where the symbols are as defined in the specification, and the R group includes at least one acidic group or its pharmaceutically acceptable salt, have improved aqueous solubility and bioavailability.